https://www.hmpgloballearningnetwork.com/site/frmc/news/immune-checkpoint-inhibitor-regimens-drive-higher-costs-first-line-nsclc-treatment
Immune Checkpoint Inhibitor Regimens Drive Higher Costs in First-Line NSCLC Treatment
First-line (1L) treatment with immune checkpoint inhibitors (ICIs), particularly in combination with chemotherapy, is the most frequently used and costliest...
immune checkpoint inhibitor
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1369268/full
Frontiers | Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival
Objectives: Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs), of which endocrinopathies are common. We character...
immune checkpoint inhibitorfrontierseffects
https://www.mskcc.org/cancer-care/diagnosis-treatment/cancer-treatments/immunotherapy/checkpoint-inhibitors
Immune Checkpoint Inhibitor Cancer Treatment | Memorial Sloan Kettering Cancer Center
Checkpoint inhibitors work by releasing a natural brake on your immune system so that immune cells called T cells recognize and attack tumors.
immune checkpoint inhibitormemorial sloan ketteringcancer treatmentcenter
https://pmc.ncbi.nlm.nih.gov/articles/PMC10727689/
Circadian lifestyle determinants of immune checkpoint inhibitor efficacy - PMC
Immune Checkpoint Inhibitors (ICI) have revolutionised cancer care in recent years. Despite a global improvement in the efficacy and tolerability of systemic...
immune checkpoint inhibitorcircadianlifestyledeterminantsefficacy
https://www.aacr.org/about-the-aacr/newsroom/news-releases/bispecific-immune-checkpoint-inhibitor-improves-survival-in-gastric-cancer-patients-regardless-of-pd-l1-status/
Bispecific Immune Checkpoint Inhibitor Improves Survival in Gastric Cancer Patients Regardless of...
Apr 7, 2024 - Bispecific Immune Checkpoint Inhibitor Improves Survival in Gastric Cancer Patients Regardless of PD-L1 Status
immune checkpoint inhibitor
https://pmc.ncbi.nlm.nih.gov/articles/PMC11610551/
The role of artificial intelligence in immune checkpoint inhibitor research: A bibliometric...
Immune checkpoint inhibitors (ICIs) are revolutionizing cancer treatment, and Artificial Intelligence (AI) is a key player in this field. A comprehensive...
immune checkpoint inhibitorthe roleartificial intelligence
https://www.oulu.fi/en/theses/real-world-perspectives-cancer-patients-receiving-immune-checkpoint-inhibitor-therapies
Real-world perspectives on cancer patients receiving immune checkpoint inhibitor therapies |...
immune checkpoint inhibitorreal worldcancer patientsperspectives
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1542293/full
Frontiers | Immune checkpoint inhibitor outcomes and prognostic factors in gynecologic tract...
IntroductionGynecologic tract melanoma (GTM) is a rare and aggressive malignancy with limited treatment options and poor prognosis. This study aims to evalua...
immune checkpoint inhibitorprognostic factorsfrontiersoutcomes
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1108116/full
Frontiers | Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological...
Background: Neurological immune-related adverse events (irAE-n) are severe and potentially fatal toxicities of immune checkpoint inhibitors (ICI). To date, t...
immune checkpoint inhibitorfrontiersautoantibodyprofilespatients
https://pmc.ncbi.nlm.nih.gov/articles/PMC10626011/
Gut microbiome on immune checkpoint inhibitor therapy and consequent immune-related colitis: a...
Immune checkpoint inhibitors have dramatically revolutionized the therapeutic landscape for patients with advanced malignancies. Recently, convincing evidence...
immune checkpoint inhibitorgut microbiome
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.998620/full
Frontiers | Neoadjuvant immune checkpoint inhibitor in combination with chemotherapy or...
Background: Neoadjuvant immune checkpoint inhibitor in combination with chemotherapy (nICT) or chemoradiotherapy (nICRT) has been tested in resectable esopha...
immune checkpoint inhibitorfrontiersneoadjuvantcombinationchemotherapy
https://www.dana-farber.org/newsroom/news-releases/2025/adding-immune-checkpoint-inhibitor-to-standard-chemotherapy-regimen-improves-outcomes-in-stage-3-colon-cancer-study-finds
Adding Immune Checkpoint Inhibitor to Standard Chemotherapy Regimen Improves Outcomes in Stage 3...
Combining standard adjuvant chemotherapy with an immune checkpoint inhibitor (atezolizumab) leads to a significant improvement in disease-free survival in a...
immune checkpoint inhibitor
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2019.00119/full
Frontiers | Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events
In the last decade, inhibitors targeting immune checkpoint molecules such as cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death 1 (PD-1) and pr...
immune checkpoint inhibitor
https://www.healthday.com/healthpro-news/cancer/immune-checkpoint-inhibitor-affordability-tied-to-widening-survival-disparity
Immune Checkpoint Inhibitor Tied to Widening Survival Disparity
The introduction of immune checkpoint inhibitors was associated with a widening survival disparity between those with private insurance and those without...
immune checkpoint inhibitortiedwideningsurvivaldisparity
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.964335/full
Frontiers | The role of kidney biopsy in immune checkpoint inhibitor nephrotoxicity
Immune checkpoint inhibitors, medications that boost host immune response to tumor cells, are now at the forefront of anti-cancer therapy. While efficacious ...
immune checkpoint inhibitorthe rolekidney biopsyfrontiers
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.1088659/full
Frontiers | Immune checkpoint inhibitor-induced myocarditis and myositis in liver cancer patients:...
With the development of immunotherapy, immune checkpoint inhibitors (ICIs) are widely used in clinical oncology and have achieved good results. ICIs could in...
immune checkpoint inhibitor
https://www.uclahealth.org/clinical-trials/abatacept-immune-checkpoint-inhibitor-myocarditis
Other Cancer UCLA Clinical Trial | Abatacept in Immune Checkpoint Inhibitor Myocarditis | UCLA...
immune checkpoint inhibitorclinical trialcancerucla
https://www.mdanderson.org/patients-family/diagnosis-treatment/emotional-physical-effects/immune-checkpoint-inhibitor-side-effects.html
Immune Checkpoint Inhibitor Side Effects | UT MD Anderson
immune checkpoint inhibitorside effectsutmdanderson
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immune-checkpoint-inhibitor
Definition of immune checkpoint inhibitor - NCI Dictionary of Cancer Terms - NCI
NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine.
immune checkpoint inhibitordefinition ofncidictionarycancer
https://pmc.ncbi.nlm.nih.gov/articles/PMC8107031/
Recombinant human adenovirus type 5 (Oncorine) reverses resistance to immune checkpoint inhibitor...
Immune checkpoint inhibitors (ICIs) have shown significant efficacy in various solid tumors, but only a small subgroup of patients benefit from them because of...
human adenovirustype 5
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1533556/full
Frontiers | The effect of baseline versus early glucocorticoid use on immune checkpoint inhibitor...
PurposeThis study aims to investigate the specific effects of glucocorticoids (GC) on the efficacy of immune checkpoint inhibitors (ICIs), and whether this e...
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.685370/full
Frontiers | Influence of Tumor Immune Infiltration on Immune Checkpoint Inhibitor Therapeutic...
The tumor immune microenvironment (TIME) is likely an important determinant of sensitivity to immune checkpoint inhibitor (ICI) treatment. However, a compreh...
checkpoint inhibitorfrontiersinfluencetumorimmune
https://www.uclahealth.org/clinical-trials/jak-inhibitor-reversal-immune-checkpoint-inhibitor-diabetes
Breast Cancer UCLA Clinical Trial | JAK INHIBITOR FOR REVERSAL OF IMMUNE CHECKPOINT INHIBITOR...
breast cancerclinical trialjak inhibitor
https://www.preprints.org/manuscript/202409.0006
Regulatory Role of IL-6 in Immune-Related Adverse Events During Checkpoint Inhibitor Treatment in...
The landscape of clinical management for metastatic melanoma (MM) and other solid tumors has been modernized by the advent of immune checkpoint inhibitors...
https://stockhouse.com/news/press-releases/2025/08/25/hcw-biologics-to-showcase-its-novel-second-generation-immune-checkpoint
2025-08-25 | HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor...
(2025-08-25 | NDAQ:HCWB) HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion...
https://www.spandidos-publications.com/10.3892/ol.2026.15616?text=fulltext
Evaluation of smoking status as a prognostic factor under immune checkpoint inhibitor treatment: A...
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
https://www.hmpgloballearningnetwork.com/site/onc/news/survival-outcomes-immune-checkpoint-and-mtor-inhibitors-patients-glioblastoma
Survival Outcomes of Immune Checkpoint and mTOR Inhibitor Therapies for Patients With Glioblastoma
Neither immune checkpoint nor mTOR inhibitors consistently improved survival in unselected glioblastoma populations. However, tailored approaches based on...
https://www.spandidos-publications.com/10.3892/ol.2026.15616
Evaluation of smoking status as a prognostic factor under immune checkpoint inhibitor treatment: A...
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
https://www.mdpi.com/1718-7729/29/9/492
Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer
Tobacco is a known risk factor for lung cancer, and continued tobacco use is associated with poorer outcomes across multiple lung cancer treatment modalities...
https://www.businesswire.com/news/home/20210627005058/en/Exelixis-and-Ipsen-Announce-Cabozantinib-in-Combination-with-an-Immune-Checkpoint-Inhibitor-Significantly-Improved-Progression-Free-Survival-in-Phase-3-COSMIC-312-Pivotal-Trial-in-Patients-with-Previously-Untreated-Advanced-Liver-Cancer
Exelixis and Ipsen Announce Cabozantinib in Combination with an Immune Checkpoint Inhibitor...
Regulatory News: Exelixis, Inc. (NASDAQ: EXEL) and Ipsen (Euronext: IPN; ADR: IPSEY) today announced that COSMIC-312, the ongoing phase 3 pivotal trial evalu...